Molecular mechanisms of cartilage remodelling in osteoarthritis

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 10, 2010, Pages 1594-1601

  Bertrand, Jessica ^a   Cromme, Christoph ^a   Umlauf, Daniel ^a   Frank, Svetlana ^a   Pap, Thomas ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Cartilage; Chondrocytes; Osteoarthritis

Indexed keywords

INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; PYROPHOSPHATE; TRANSFORMING GROWTH FACTOR BETA;

BONE MINERALIZATION; BONE REMODELING; CARTILAGE; CARTILAGE CELL; CELL FUNCTION; CELL INTERACTION; CELL METABOLISM; EXTRACELLULAR MATRIX; HUMAN; OSTEOARTHRITIS; PATHOGENESIS; SHORT SURVEY;

ANIMALS; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; CARTILAGE, ARTICULAR; CELL ADHESION; CELL DIFFERENTIATION; CHONDROCYTES; EXTRACELLULAR MATRIX; HUMANS; OSTEOARTHRITIS;

EID: 77956182476     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.06.022     Document Type: Short Survey

References (110)

1. Abbaszade I., Liu R.Q., Yang F., Rosenfeld S.A., Ross O.H., Link J.R., et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 1999, 274(33):23443-23450.
2. Adams B.D., Samani J.E., Holley K.A. Triangular fibrocartilage injury: a laboratory model. J Hand Surg Am 1996, 21(2):189-193.
3. Aigner T., McKenna L. Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol Life Sci 2002, 59(1):5-18.
4. Aigner T., Soder S., Gebhard P.M., McAlinden A., Haag J. Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis-structure, chaos and senescence. Nat Clin Pract Rheumatol 2007, 3(7):391-399.
5. Alt V., Pfefferle H.J., Kreuter J., Stahl J.P., Pavlidis T., Meyer C., et al. Effect of glycerol-l-lactide coating polymer on bone ingrowth of bFGF-coated hydroxyapatite implants. J Control Release 2004, 99(1):103-111.
6. Barcellos-Hoff M.H, Dix T.A. Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 1996, 10(9):1077-1083.
7. Bergwitz C., Wendlandt T., Kispert A., Brabant G. Wnts differentially regulate colony growth and differentiation of chondrogenic rat calvaria cells. Biochim Biophys Acta 2001, 1538(2-3):129-140.
8. Blom E.J., Klein-Nulend J., Wolke J.G., van Waas M.A., Driessens F.C., Burger E.H. Transforming growth factor-beta1 incorporation in a calcium phosphate bone cement: material properties and release characteristics. J Biomed Mater Res 2002, 59(2):265-272.
9. Bondeson J., Wainwright S., Hughes C., Caterson B. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin Exp Rheumatol 2008, 26(1):139-145.
10. Brew C.J., Clegg P.D., Boot-Handford R.P., Andrew J.G., Hardingham T. Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy. Ann Rheum Dis 2008, 69(1):234-240.
11. Brooks P.M. The burden of musculoskeletal disease-a global perspective. Clin Rheumatol 2006, 25(6):778-781.
12. Buckwalter J.A, Brown T.D. Joint injury, repair, and remodeling: roles in post-traumatic osteoarthritis. Clin Orthop Relat Res 2004, (423):7-16.
13. Cailotto F., Sebillaud S., Netter P., Jouzeau J.Y., Bianchi A. The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte. J Biol Chem 2010, 285(14):10572-10582.
14. Cancedda R., Castagnola P., Cancedda F.D., Dozin B., Quarto R. Developmental control of chondrogenesis and osteogenesis. Int J Dev Biol 2000, 44(6):707-714.
15. Chambers M.G., Cox L., Chong L., Suri N., Cover P., Bayliss M.T., et al. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice. Arthritis Rheum 2001, 44(6):1455-1465.
16. Cheung H.S Role of calcium-containing crystals in osteoarthritis. Front Biosci 2005, 10:1336-1340.
17. Chia S.L., Sawaji Y., Burleigh A., McLean C., Inglis J., Saklatvala J., et al. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum 2009, 60(7):2019-2027.
18. Choy E.H, Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001, 344(12):907-916.
19. Colman A., Byers M.J., Primrose S.B., Lyons A. Rapid purification of plasmid DNAs by hydroxyapatite chromatography. Eur J Biochem 1978, 91(1):303-310.
20. Cornelison D.D., Filla M.S., Stanley H.M., Rapraeger A.C., Olwin B.B. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol 2001, 239(1):79-94.
21. Cs-Szabo G., Roughley P.J., Plaas A.H., Glant T.T. Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum 1995, 38(5):660-668.
22. Dell'Accio F., De Bari C., El Tawil N.M., Barone F., Mitsiadis T.A., O'Dowd J., et al. Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury. Arthritis Res Ther 2006, 8(5):R139.
23. Dell'accio F., De Bari C., Eltawil N.M., Vanhummelen P., Pitzalis C. Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. Arthritis Rheum 2008, 58(5):1410-1421.
24. Diarra D., Stolina M., Polzer K., Zwerina J., Ominsky M.S., Dwyer D., et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007, 13(2):156-163.
25. Dreier R., Gunther B.K., Mainz T., Nemere I., Bruckner P. Terminal differentiation of chick embryo chondrocytes requires shedding of a cell surface protein that binds 1,25-dihydroxyvitamin D3. J Biol Chem 2008, 283(2):1104-1112.
26. Dreier R., Opolka A., Grifka J., Bruckner P., Grassel S. Collagen IX-deficiency seriously compromises growth cartilage development in mice. Matrix Biol 2008, 27(4):319-329.
27. Ea H.K., Liote F. Calcium pyrophosphate dihydrate and basic calcium phosphate crystal-induced arthropathies: update on pathogenesis, clinical features, and therapy. Curr Rheumatol Rep 2004, 6(3):221-227.
28. Ea H.K, Liote F. Advances in understanding calcium-containing crystal disease. Curr Opin Rheumatol 2009, 21(2):150-157.
29. Echtermeyer F., Bertrand J., Dreier R., Meinecke I., Neugebauer K., Fuerst M., et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 2009, 15(9):1072-1076.
30. Echtermeyer F., Streit M., Wilcox-Adelman S., Saoncella S., Denhez F., Detmar M., et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 2001, 107(2):R9-R14.
31. Fernandes J.C., Martel-Pelletier J., Lascau-Coman V., Moldovan F., Jovanovic D., Raynauld J.P., et al. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study. J Rheumatol 1998, 25(8):1585-1594.
32. Fuerst M., Bertrand J., Lammers L., Dreier R., Echtermeyer F., Nitschke Y., et al. Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum 2009, 60(9):2694-2703.
33. Furuzawa-Carballeda J., Macip-Rodriguez P.M., Cabral A.R. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response. Clin Exp Rheumatol 2008, 26(4):554-560.
34. Goldring M.B Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol 2006, 20(5):1003-1025.
35. Goldring M.B., Birkhead J.R., Suen L.F., Yamin R., Mizuno S., Glowacki J., et al. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Invest 1994, 94(6):2307-2316.
36. Goldring M.B., Tsuchimochi K., Ijiri K. The control of chondrogenesis. J Cell Biochem 2006, 97(1):33-44.
37. Hagg R., Bruckner P., Hedbom E. Cartilage fibrils of mammals are biochemically heterogeneous: differential distribution of decorin and collagen IX. J Cell Biol 1998, 142(1):285-294.
38. Hakim F.T., Cranley R., Brown K.S., Eanes E.D., Harne L., Oppenheim J.J. Hereditary joint disorder in progressive ankylosis (ank/ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy. Arthritis Rheum 1984, 27(12):1411-1420.
39. Hessle L., Johnson K.A., Anderson H.C., Narisawa S., Sali A., Goding J.W., et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 2002, 99(14):9445-9449.
40. Ho A.M., Johnson M.D., Kingsley D.M. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000, 289(5477):265-270.
41. Hochberg M.C. Epidemiologic considerations in the primary prevention of osteoarthritis. J Rheumatol 1991, 18(10):1438-1440.
42. Hossain M., Irwin R., Baumann M.J., McCabe L.R. Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces. Biomaterials 2005, 26(15):2595-2602.
43. Hwang S.G., Ryu J.H., Kim I.C., Jho E.H., Jung H.C., Kim K., et al. Wnt-7a causes loss of differentiated phenotype and inhibits apoptosis of articular chondrocytes via different mechanisms. J Biol Chem 2004, 279(25):26597-26604.
44. Johnson K., Hashimoto S., Lotz M., Pritzker K., Goding J., Terkeltaub R. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 2001, 44(5):1071-1081.
45. Johnson K., Moffa A., Chen Y., Pritzker K., Goding J., Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Miner Res 1999, 14(6):883-892.
46. Johnson K., Pritzker K., Goding J., Terkeltaub R. The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles. J Rheumatol 2001, 28(12):2681-2691.
47. Johnson K., Vaingankar S., Chen Y., Moffa A., Goldring M.B., Sano K., et al. Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. Arthritis Rheum 1999, 42(9):1986-1997.
48. Kirkham S.G, Samarasinghe R.K. Review article: glucosamine. J Orthop Surg (Hong Kong) 2009, 17(1):72-76.
49. Knecht S., Vanwanseele B., Stussi E. A review on the mechanical quality of articular cartilage-implications for the diagnosis of osteoarthritis. Clin Biomech (Bristol. Avon) 2006, 21(10):999-1012.
50. Kotlarz H., Gunnarsson C.L., Fang H., Rizzo J.A. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum 2009, 60(12):3546-3553.
51. Kronenberg H.M Developmental regulation of the growth plate. Nature 2003, 423(6937):332-336.
52. Lim S.T., Longley R.L., Couchman J.R., Woods A. Direct binding of syndecan-4 cytoplasmic domain to the catalytic domain of protein kinase C alpha (PKC alpha) increases focal adhesion localization of PKC alpha. J Biol Chem 2003, 278(16):13795-13802.
53. Lin A.C., Seeto B.L., Bartoszko J.M., Khoury M.A., Whetstone H., Ho L., et al. Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 2009, 15(12):1421-1425.
54. Little C.B., Barai A., Burkhardt D., Smith S.M., Fosang A.J., Werb Z., et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 2009, 60(12):3723-3733.
55. Lohmander L.S., Ionescu M., Jugessur H., Poole A.R. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum 1999, 42(3):534-544.
56. Longpre J.M., McCulloch D.R., Koo B.H., Alexander J.P., Apte S.S., Leduc R. Characterization of proADAMTS5 processing by proprotein convertases. Int J Biochem Cell Biol 2009, 41(5):1116-1126.
57. Lories R.J., Derese I., Luyten F.P. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 2005, 115(6):1571-1579.
58. Lories R.J., Luyten F.P. Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev 2005, 16(3):287-298.
59. Lotz M., Rosen F., McCabe G., Quach J., Blanco F., Dudler J., et al. Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci USA 1995, 92(22):10364-10368.
60. Loughlin J. Crystals in hand. Arthritis Res Ther 2005, 7(5):187-188.
61. Luyten F.P., Tylzanowski P., Lories R.J. Wnt signaling and osteoarthritis. Bone 2009, 44(4):522-527.
62. Majeska R.J., Wuthier R.E. Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochim Biophys Acta 1975, 391(1):51-60.
63. Malemud C.J., Papay R.S., Hering T.M., Holderbaum D., Goldberg V.M., Haqqi T.M. Phenotypic modulation of newly synthesized proteoglycans in human cartilage and chondrocytes. Osteoarthritis Cartilage 1995, 3(4):227-238.
64. Martel-Pelletier J., Alaaeddine N., Pelletier J.P. Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 1999, 4:D694-703.
65. Martel-Pelletier J., Boileau C., Pelletier J.P., Roughley P.J. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol 2008, 22(2):351-384.
66. Moldovan F., Pelletier J.P., Hambor J., Cloutier J.M., Martel-Pelletier J. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta. Arthritis Rheum 1997, 40(9):1653-1661.
67. Molteni A., Modrowski D., Hott M., Marie P.J. Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro. Bone 1999, 24(4):337-347.
68. Morales T.I. Chondrocyte moves: clever strategies?. Osteoarthritis Cartilage 2007, 15(8):861-871.
69. Moss D.W., Eaton R.H., Smith J.K., Whitby L.G. Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations. Biochem J 1967, 102(1):53-57.
70. Muller-Glauser W., Humbel B., Glatt M., Strauli P., Winterhalter K.H., Bruckner P. On the role of type IX collagen in the extracellular matrix of cartilage: type IX collagen is localized to intersections of collagen fibrils. J Cell Biol 1986, 102(5):1931-1939.
71. Nakamura Y., Nawata M., Wakitani S. Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am J Pathol 2005, 167(1):97-105.
72. Olmez U., Ryan L.M., Kurup I.V., Rosenthal A.K. Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta1-stimulated chondrocytes and cartilage. Osteoarthritis Cartilage 1994, 2(3):149-154.
73. Pattoli M.A., MacMaster J.F., Gregor K.R., Burke J.R. Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression. J Pharmacol Exp Ther 2005, 315(1):382-388.
74. Pelletier J.P., Martel-Pelletier J., Abramson S.B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001, 44(6):1237-1247.
75. Poole A.R., Nelson F., Dahlberg L., Tchetina E., Kobayashi M., Yasuda T., et al. Proteolysis of the collagen fibril in osteoarthritis. Biochem Soc Symp 2003, (70):115-123.
76. Pritzker K.P. Animal models for osteoarthritis: processes, problems and prospects. Ann Rheum Dis 1994, 53(6):406-420.
77. Provot S, Schipani E. Molecular mechanisms of endochondral bone development. Biochem Biophys Res Commun 2005, 328(3):658-665.
78. Rezende A.A., Pizauro J.M., Ciancaglini P., Leone F.A. Phosphodiesterase activity is a novel property of alkaline phosphatase from osseous plate. Biochem J 1994, 301(Pt 2):517-522.
79. Ripamonti U., Yeates L., van den Heever B. Initiation of heterotopic osteogenesis in primates after chromatographic adsorption of osteogenin, a bone morphogenetic protein, onto porous hydroxyapatite. Biochem Biophys Res Commun 1993, 193(2):509-517.
80. Rutsch F, Terkeltaub R. Parallels between arterial and cartilage calcification: what understanding artery calcification can teach us about chondrocalcinosis. Curr Opin Rheumatol 2003, 15(3):302-310.
81. Ryu J.H., Chun J.S. Opposing roles of WNT-5A and WNT-11 in interleukin-1beta regulation of type II collagen expression in articular chondrocytes. J Biol Chem 2006, 281(31):22039-22047.
82. Ryu J.H., Kim S.J., Kim S.H., Oh C.D., Hwang S.G., Chun C.H., et al. Regulation of the chondrocyte phenotype by beta-catenin. Development 2002, 129(23):5541-5550.
83. Saoncella S., Echtermeyer F., Denhez F., Nowlen J.K., Mosher D.F., Robinson S.D., et al. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Natl Acad Sci USA 1999, 96(6):2805-2810.
84. Schett G., Zwerina J., David J.P. The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol 2008, 4(9):473-480.
85. Schroder E., Jonsson T., Poole L. Hydroxyapatite chromatography: altering the phosphate-dependent elution profile of protein as a function of pH. Anal Biochem 2003, 313(1):176-178.
86. Sohn P., Crowley M., Slattery E., Serra R. Developmental and TGF-beta-mediated regulation of Ank mRNA expression in cartilage and bone. Osteoarthritis Cartilage 2002, 10(6):482-490.
87. Song R.H., Tortorella M.D., Malfait A.M., Alston J.T., Yang Z., Arner E.C., et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 2007, 56(2):575-585.
88. Stetler-Stevenson W.G., Aznavoorian S., Liotta L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993, 9:541-573.
89. Struglics A., Larsson S., Pratta M.A., Kumar S., Lark M.W., Lohmander L.S. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage 2006, 14(2):101-113.
90. Sugiki T., Uyama T., Toyoda M., Morioka H., Kume S., Miyado K., Matsumoto K., et al. Hyaline cartilage formation and enchondral ossification modeled with KUM5 and OP9 chondroblasts. J Cell Biochem 2007, 100(5):1240-1254.
91. Suk E.K., Malkin I., Dahm S., Kalichman L., Ruf N., Kobyliansky E., et al. Association of ENPP1 gene polymorphisms with hand osteoarthritis in a Chuvasha population. Arthritis Res Ther 2005, 7(5):R1082-R1090.
92. Sumner D.R., Turner T.M., Urban R.M., Virdi A.S., Inoue N. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model. J Bone Joint Surg Am 2006, 88(4):806-817.
93. Terkeltaub R., Rosenbach M., Fong F., Goding J. Causal link between nucleotide pyrophosphohydrolase overactivity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glycoprotein-1 Relevance to calcium pyrophosphate dihydrate deposition disease. Arthritis Rheum 1994, 37(6):934-941.
94. Terkeltaub R.A. Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 2001, 281(1):C1-C11.
95. Tetlow L.C., Woolley D.E. Histamine stimulates matrix metalloproteinase-3 and -13 production by human articular chondrocytes in vitro. Ann Rheum Dis 2002, 61(8):737-740.
96. Tetlow L.C., Woolley D.E. Effect of histamine on the production of matrix metalloproteinases-1, -3, -8 and -13, and TNFalpha and PGE(2) by human articular chondrocytes and synovial fibroblasts in vitro: a comparative study. Virchows Arch 2004, 445(5):485-490.
97. Tkachenko E., Rhodes J.M., Simons M. Syndecans: new kids on the signaling block. Circ Res 2005, 96(5):488-500.
98. Topol L., Jiang X., Choi H., Garrett-Beal L., Carolan P.J., Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 2003, 162(5):899-908.
99. Tortorella M.D., Arner E.C., Hills R., Gormley J., Fok K., Pegg L., et al. ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms. Arch Biochem Biophys 2005, 444(1):34-44.
100. Tortorella M.D., Arner E.C., Hills R., Gormley J., Fok K., Pegg L., et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999, 284(5420):1664-1666.
101. Tortorella M.D., Liu R.Q., Burn T., Newton R.C., Arner E. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 2002, 21(6):499-511.
102. van den Berg W.B. Growth factors in experimental osteoarthritis: transforming growth factor beta pathogenic?. J Rheumatol Suppl 1995, 43:143-145.
103. van der Kraan P.M., Blaney Davidson E.N., van den Berg W.B. Bone morphogenetic proteins and articular cartilage to serve and protect or a wolf in sheep clothing's?. Osteoarthritis Cartilage 2010.
104. von der Mark K., Kirsch T., Nerlich A., Kuss A., Weseloh G., Gluckert K., et al. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 1992, 35(7):806-811.
105. Wang P., Tortorella M., England K., Malfait A.M., Thomas G., Arner E.C., et al. Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network. J Biol Chem 2004, 279(15):15434-15440.
106. Wilcox-Adelman S.A., Denhez F., Goetinck P.F. Syndecan-4 modulates focal adhesion kinase phosphorylation. J Biol Chem 2002, 277(36):32970-32977.
107. Wipff P.J., Hinz B. Integrins and the activation of latent transforming growth factor beta1-an intimate relationship. Eur J Cell Biol 2008, 87(8-9):601-615.
108. Wong M., Carter D.R. Articular cartilage functional histomorphology and mechanobiology: a research perspective. Bone 2003, 33(1):1-13.
109. Zhai G., van Meurs J.B., Livshits G., Meulenbelt I., Valdes A.M., Soranzo N., et al. A genome-wide association study suggests that a locus within the ataxin 2 binding protein 1 gene is associated with hand osteoarthritis: the Treat-OA consortium. J Med Genet 2009, 46(9):614-616.
110. Zhao Q., Eberspaecher H., Lefebvre V., De Crombrugghe B. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 1997, 209(4):377-386.